Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Are Hemoglobin Levels Elevated in Type 1 Diabetes?

  1. Baqiyyah N. Conway, PHD,
  2. Rachel G. Miller, MS and
  3. Trevor J. Orchard, MD
  1. From the Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvantia.
  1. Corresponding author: Trevor J. Orchard, orchardt{at}edc.pitt.edu.
Diabetes Care 2010 Feb; 33(2): 341-343. https://doi.org/10.2337/dc09-0713
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE While lower hemoglobin is generally associated with adverse events in diabetes, we have recently observed in type 1 diabetes that those with overt nephropathy had hemoglobin levels as high as 18.8 g/dl. We thus explored whether hemoglobin concentrations are generally higher in type 1 diabetes.

RESEARCH DESIGN AND METHODS Baseline (1986–1988) hemoglobin levels from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC) of type 1 diabetes were compared with general population data from the National Health and Nutrition Examination Survey (NHANES) III in the same age range as the EDC population (aged 8–48 years).

RESULTS Both male and female EDC study participants had significantly higher hemoglobin levels than their NHANES III counterparts (men: 16.0 vs. 15.1 g/dl, P < 0.0001; women: 14.1 vs. 13.3 g/dl, P < 0.0001). The difference between the two populations was greatest in adolescent female subjects.

CONCLUSIONS Hemoglobin levels may be higher in type 1 diabetes than in the general population, which may have important clinical implications.

Although low hemoglobin is generally associated with adverse events in diabetes (1) and kidney disease (2), we have recently observed relatively high hemoglobin levels (as high as 18.8 g/dl) among individuals with type 1 diabetes and overt nephropathy (3) compared with the general renal disease population (4). This led us to question whether hemoglobin levels are generally elevated in type 1 diabetes. We therefore assessed 652 individuals from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC) of type 1 diabetes and compared the hemoglobin levels observed with those of the general National Health and Nutrition Examination Survey (NHANES) III population.

RESEARCH DESIGN AND METHODS

EDC is a 20-year prospective study based on a well-defined cohort with childhood onset (aged <17 years) type 1 diabetes living within 100 miles of the University of Pittsburgh at study baseline (5,6). For these analyses, baseline data (1986–1988) from 652 participants (50.5% female, 98% Caucasian) were examined. Blood samples were assayed for hemoglobin and A1C. Overt nephropathy was defined as albumin excretion rate >200 μg/min or dialysis/renal transplantation.

Hemoglobin in EDC was measured using the Coulter Counter Model S-Plus IV automated blood cell counter (Coulter Electronics, Hialeah, FL). General population comparison data were retrieved from NHANES III (years 1988–1994) (7) for Caucasians in the same age range as the EDC population (i.e., aged 8–48 years). Hemoglobin in NHANES III was measured using a semiautomated cell counter (Coulter hemoglobinometer) (7).

Appropriate sampling weights were used to obtain unbiased estimates of hemoglobin means and SEs in NHANES III. These sampling weights account for the complex design of the NHANES III survey, including oversampling of certain subgroups and nonresponse bias, and provide estimates that are representative of the noninstitutionalized U.S. population. Mean hemoglobin levels were calculated using PROC Surveymeans in SAS 9.1.3 (SAS Institute, Cary, NC).

RESULTS

Hemoglobin ranged from 8.3 to 20.0 g/dl in EDC and from 5.2 to 18.7 g/dl in NHANES III. Relative to the general population, EDC participants had higher hemoglobin levels overall (15.1 vs. 14.2 g/dl, P < 0.0001) (Fig. 1) and sex specifically (men: 16.0 vs. 15.1 g/dl, P < 0.0001; women: 14.1 vs. 13.3 g/dl, P < 0.0001).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Hemoglobin distributions in EDC and NHANES III. A: Hemoglobin distribution in NHANES III and EDC populations. B: Hemoglobin levels in NHANES III and EDC male subjects by age-group. Solid line, NHANES III. Dotted line, EDC. C: Hemoglobin levels in NHANES III and EDC female subjects by age-group. Solid line, NHANES III. Dotted line, EDC.

The difference between the two populations was greatest in teenage females; girls aged 15–19 years with type 1 diabetes had hemoglobin levels ∼2 g/dl higher than similarly aged NHANES III females; the difference in boys was ∼1 g/dl. EDC teenage girls had hemoglobin levels similar to those of NHANES III teenage boys (Fig. 1). In male subjects with type 1 diabetes, hemoglobin levels were stable until about age 14 years, when they began to rise, peaking at 16.9 g/dl at approximately age 22 years. A similar rise in hemoglobin, though less steep, was seen in NHANES III male subjects (Fig. 1). In female subjects with type 1 diabetes, hemoglobin levels did not display the same pattern of a constant rise throughout adolescence observed in male subjects, but rose sharply, by 1.6 g/dl, at the beginning of their teens, remaining elevated throughout the teen years, peaking at 15.0 g/dl. In contrast, in NHANES III female subjects aged 12–19 years, hemoglobin remained constant (Fig. 1).

In the general population adults, hemoglobin levels remained relatively stable in both sexes. In the EDC type 1 diabetic population, hemoglobin in male subjects began to drop in their mid-20s whereas in female subjects, this occurred earlier (Fig. 1). The decline in hemoglobin in adult type 1 diabetic male subjects could be explained by overt nephropathy, as those without overt nephropathy showed no decline in adulthood after their mid-20s. In adult type 1 diabetic female subjects, this difference by overt nephropathy status was less marked. Women without overt nephropathy still showed this age-related decline, and the difference by overt nephropathy status did not reach statistical significance until age 40 years (online appendix Fig. 1 [available at http://care.diabetesjournals.org/cgi/content/full/dc09-0713/DC1]).

To determine whether the elevated hemoglobin observed in EDC subjects might simply be due to increased hemoconcentration from dehydration secondary to poor glycemic control, analyses were repeated with EDC participants restricted to those with 1) A1C levels greater than or equal to the median and 2) A1C levels less than or equal to the median. Similar results were obtained to those in Fig. 1.

In a subanalysis, hemoglobin levels in our 13 African American female subjects with type 1 diabetes (aged 18–39 years) did not differ from our Caucasian female subjects (13.7 vs. 14.1 g/dl, P = 0.20) but were significantly higher than NHANES III African American female subjects (13.7 vs. 12.4 g/dl, P < 0.0001). Hemoglobin levels significantly differed between NHANES III African American and Caucasian female subjects (12.4 vs. 13.2 g/dl, P < 0.0001). Sample size prohibited formal analyses in males.

CONCLUSIONS

We have demonstrated that hemoglobin levels are higher in type 1 diabetes than in the general population, by ∼1 g/dl. To our knowledge, this is the first report to document this finding. We have shown that this difference is greatest for adolescent females, particularly striking since in the general population the adolescent rise in hemoglobin is only observed in male subjects (8). Although hemoglobin levels began to decline in type 1 diabetes in the early to mid-20s this decline was not observed in the general population. In men with type 1 diabetes, kidney disease largely accounted for this decline. The increase in hemoglobin was unrelated to glycemic control.

Potential explanations include a response to generalized hypoxia secondary to vascular disease, or a response to testosterone, which has been reported to be increased in type 1 diabetes (9,10). In addition to the erythropoietic effects of testosterone, insulin and insulin-like growth factor-1 and -2 stimulate erythropoietin production in astrocytes (11). Finally, intermittent ketosis might lead to increased β-hydroxy-butyrate, resulting in higher fetal hemoglobin (12) and hence total hemoglobin levels. Elevated fetal hemoglobin has been observed in both children and adults with type 1 diabetes and correlated only weakly (13), or not at all (14), with glycemic control but increased in adolescence (14). These data have potentially important clinical implications not only for interpreting hemoglobin values in type 1 diabetes but also for complications, as we have recently reported that high hemoglobin is a risk factor for proliferative retinopathy in men; while in women, who are more likely to be in the normal to low end of the hemoglobin distribution, a U-shaped relationship exists (15).

Acknowledgments

This work was supported by National Institutes of Health Grant DK34818.

No potential conflicts of interest relevant to this article were reported.

We thank the EDC participants for their dedicated participation.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received April 14, 2009.
    • Accepted November 2, 2009.
  • Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

  • © 2010 by the American Diabetes Association.

References

  1. ↵
    1. Thomas M,
    2. MacIsaac R,
    3. Tsalamandris C,
    4. Molyneaux L,
    5. Goubina I,
    6. Fulcher G,
    7. Yue D,
    8. Jerums G
    . Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2004; 89: 4359– 4363
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Levin A,
    2. Thompson C,
    3. Ethier J,
    4. Carlisle E,
    5. Tobe S,
    6. Mendelsshon D,
    7. Burgess E,
    8. Jindal K,
    9. Barrett B,
    10. Singer J,
    11. Djurdjev O
    . Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125– 134
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Conway B,
    2. Fried L,
    3. Orchard T
    . Hemoglobin and overt nephropathy complication in type 1 diabetes. Ann Epidemiol 2008; 18: 147– 155
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47: S11– S145
    OpenUrlCrossRefPubMed
  5. ↵
    1. Orchard T,
    2. Dorman J,
    3. Maser R,
    4. Becker D,
    5. Ellis J,
    6. LaPorte R,
    7. Kuller L
    . Factors associated with the avoidance of severe complications after 25 years of insulin-dependent diabetes mellitus: Pittsburgh Epidemiology of Diabetes Complications Study-I. Diabetes Care 1990; 13: 741– 747
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Orchard T,
    2. Dorman J,
    3. Maser R,
    4. Becker D,
    5. Drash A,
    6. Ellis J,
    7. LaPorte R,
    8. Kuller L
    . The prevalence of complications in insulin-dependent diabetes mellitus by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study-II. Diabetes 1990; 39: 1116– 1124
    OpenUrlAbstract/FREE Full Text
  7. ↵
    U.S. Department of Health and Human Services (DHHS), National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988–1994, NHANES III laboratory data file (CD-ROM). Public Use Data File Documentation no. 76200. Hyattsville, MD, Centers for Disease Control and Prevention, 1996
  8. ↵
    1. Krabbe S,
    2. Christensen T,
    3. Worm J,
    4. Christiansen C,
    5. Transbol I
    . Relationship between haemoglobin and serum testosterone in normal children and adolescents and in boys with delayed puberty. Acta Paediatr Scand 1978; 67: 655– 658
    OpenUrlPubMedWeb of Science
  9. ↵
    1. Meyer K,
    2. Deutscher J,
    3. Anil M,
    4. Berthold A,
    5. Bartsch M,
    6. Kiess W
    . Serum androgen levels in adolescents with type 1 diabetes: relation to pubertal stage and metabolic control. J Endocrinol Invest 2000; 23: 362– 368
    OpenUrlPubMedWeb of Science
  10. ↵
    1. Christensen L,
    2. Hagen C,
    3. Henriksen J,
    4. Haug E
    . Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus: effect of improved blood glucose regulation. Dan Med Bull 1997; 44
  11. ↵
    1. Masuda S,
    2. Chikuma M,
    3. Sasaki R
    . Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res 1997; 746: 63– 70
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Peters A,
    2. Rohloff D,
    3. Kohlmann T,
    4. Renner F,
    5. Jantscheck G,
    6. Kerner W,
    7. Fehm HL
    . Fetal hemoglobin in starvation ketosis in young women. Blood 1998; 91: 691– 694
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Diem P,
    2. Mullis P,
    3. Hirt A,
    4. Schuler JJ,
    5. Burgi W,
    6. Zuppinger K,
    7. Teuscher A
    . Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients. Diabetologia 1993; 36: 129– 132
    OpenUrlCrossRefPubMed
  14. ↵
    1. Mullis P,
    2. Schuler J,
    3. Zuppinger K
    . Increased prevalence of fetal haemoglobin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 227– 230
    OpenUrlCrossRefPubMed
  15. ↵
    1. Conway B,
    2. Rachel R,
    3. Klein R,
    4. Orchard T
    . Prediction of proliferative diabetic retinopathy with hemoglobin level. Arch Ophthalmol 2009; 127: 1494– 1499
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Diabetes Care: 33 (2)

In this Issue

February 2010, 33(2)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Are Hemoglobin Levels Elevated in Type 1 Diabetes?
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Are Hemoglobin Levels Elevated in Type 1 Diabetes?
Baqiyyah N. Conway, Rachel G. Miller, Trevor J. Orchard
Diabetes Care Feb 2010, 33 (2) 341-343; DOI: 10.2337/dc09-0713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Are Hemoglobin Levels Elevated in Type 1 Diabetes?
Baqiyyah N. Conway, Rachel G. Miller, Trevor J. Orchard
Diabetes Care Feb 2010, 33 (2) 341-343; DOI: 10.2337/dc09-0713
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study
  • Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes
  • The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
Show more Original Research

Epidemiology/Health Services Research

  • Social Deprivation and Incident Diabetes-Related Foot Disease in Patients With Type 2 Diabetes: A Population-Based Cohort Study
  • Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis
  • Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.